67 related articles for article (PubMed ID: 32207885)
41. Lepidic component at tumor margin: an independent prognostic factor in invasive lung adenocarcinoma.
Bian T; Jiang D; Feng J; Liu J; Qian L; Zhang Q; Li X; Liu Y; Zhang J
Hum Pathol; 2019 Jan; 83():106-114. PubMed ID: 30171990
[TBL] [Abstract][Full Text] [Related]
42. Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
Cheng X; Zheng D; Li Y; Li H; Sun Y; Xiang J; Chen H
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2648-2656.e2. PubMed ID: 29548592
[TBL] [Abstract][Full Text] [Related]
43. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
44. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for Stage I nonsmall cell lung cancer: A meta-analysis.
Liu Q; Wang H; Zhou D; Deng X; Min J; Dai J
J Cancer Res Ther; 2016; 12(2):926-31. PubMed ID: 27461676
[TBL] [Abstract][Full Text] [Related]
45. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis.
Razi SS; John MM; Sainathan S; Stavropoulos C
J Surg Res; 2016 Feb; 200(2):683-9. PubMed ID: 26490227
[TBL] [Abstract][Full Text] [Related]
46. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.
Travis WD; Brambilla E; Burke AP; Marx A; Nicholson AG
J Thorac Oncol; 2015 Sep; 10(9):1240-1242. PubMed ID: 26291007
[No Abstract] [Full Text] [Related]
47. Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.
Ujiie H; Kadota K; Chaft JE; Buitrago D; Sima CS; Lee MC; Huang J; Travis WD; Rizk NP; Rudin CM; Jones DR; Adusumilli PS
J Clin Oncol; 2015 Sep; 33(26):2877-84. PubMed ID: 26261257
[TBL] [Abstract][Full Text] [Related]
48. Non-small cell lung cancer: when to offer sublobar resection.
Sihoe AD; Van Schil P
Lung Cancer; 2014 Nov; 86(2):115-20. PubMed ID: 25249427
[TBL] [Abstract][Full Text] [Related]
49. The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
Izar B; Zhou H; Heist RS; Azzoli CG; Muzikansky A; Scribner EE; Bernardo LA; Dias-Santagata D; Iafrate AJ; Lanuti M
J Thorac Oncol; 2014 Sep; 9(9):1363-9. PubMed ID: 25122432
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
[TBL] [Abstract][Full Text] [Related]
51. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
[TBL] [Abstract][Full Text] [Related]
52. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.
Nitadori J; Bograd AJ; Kadota K; Sima CS; Rizk NP; Morales EA; Rusch VW; Travis WD; Adusumilli PS
J Natl Cancer Inst; 2013 Aug; 105(16):1212-20. PubMed ID: 23926067
[TBL] [Abstract][Full Text] [Related]
53. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases.
Woo T; Okudela K; Mitsui H; Tajiri M; Yamamoto T; Rino Y; Ohashi K; Masuda M
Pathol Int; 2012 Dec; 62(12):785-91. PubMed ID: 23252867
[TBL] [Abstract][Full Text] [Related]
56. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
[TBL] [Abstract][Full Text] [Related]
57. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
[TBL] [Abstract][Full Text] [Related]
58. Pathology of lung cancer.
Travis WD
Clin Chest Med; 2011 Dec; 32(4):669-92. PubMed ID: 22054879
[TBL] [Abstract][Full Text] [Related]
59. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
[TBL] [Abstract][Full Text] [Related]
60. Reduced lung-cancer mortality with low-dose computed tomographic screening.
; Aberle DR; Adams AM; Berg CD; Black WC; Clapp JD; Fagerstrom RM; Gareen IF; Gatsonis C; Marcus PM; Sicks JD
N Engl J Med; 2011 Aug; 365(5):395-409. PubMed ID: 21714641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]